GlassScriptPhysician profile
Jeffrey Dinh
NPI 1477973576
$2,488.65
in general payments reported to CMS, 2019-2025
46 companies · $196 in 2025
The $196 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.10 · 2020: $490 · 2021: $569 · 2022: $940 · 2023: $188 · 2024: $18.68 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Varian Medical Systems, INC. | $415.24 | 2020-2021 | |
| Teleflex LLC | $162.24 | 2025 | Barrigel |
| Jazz Pharmaceuticals INC. | $159.84 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $152.26 | 2019-2023 | Dupixent |
| Seagen INC. | $145.59 | 2021-2022 | |
| Boston Scientific Corporation | $123.63 | 2022 | |
| Tactile Systems Technology INC | $81.31 | 2022 | |
| Amgen INC. | $80.09 | 2020-2022 | |
| Incyte Corporation | $69.34 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $61.95 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $58.64 | 2021-2022 | |
| Myovant Sciences INC. | $57.42 | 2021-2022 | |
| Tersera Therapeutics LLC | $56.97 | 2021-2022 | |
| Sobi, INC | $54.29 | 2022 | |
| Taiho Oncology, INC. | $52.53 | 2022 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Dinh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.